Fusion Finance swings to ₹86 Cr profit YoY as credit costs halve; NPM hits 17.8%
revenue +16.8% · margins expanding
₹485.61 Cr
+16.8% YoY
₹86.48 Cr
17.81%
+22.9pp YoY
₹5.35
Fusion Finance's standalone Q2 FY27 (quarter ended September 30, 2026) PAT came in at ₹86.48 Cr, reversing a ₹22.14 Cr loss in Q2 FY26 and up 38.6% sequentially from ₹62.41 Cr — the company's own release frames this as a 39% QoQ PAT rise. Because the year-ago base was a loss, the headline comparison is a genuine turnaround rather than a growth rate; on an absolute basis the swing is ₹108.6 Cr. Revenue from operations grew a more modest 16.8% YoY (6.0% QoQ) to ₹485.61 Cr, confirming the bottom-line move is a margin story, not a volume story: net profit margin expanded to 17.81% from -5.12% a year ago and 13.62% last quarter, matching the company's own regulatory disclosure exactly.
Q2 FY-2027 vs prior quarters
The driver is squarely credit cost. Impairment on financial instruments fell 65.3% YoY to ₹38.51 Cr from ₹111.15 Cr, as the sector-wide MFI stress that produced last year's loss has eased — Gross Stage III stands at 1.60%, Net Stage III at just 0.11%, with a 93.40% provision coverage ratio, all healthy. That improvement outpaced a 12.1% YoY rise in finance costs (₹150.51 Cr) on a larger borrowing book (₹5,614.95 Cr vs ₹5,210.60 Cr at FY26-end) funding loan growth, and a modest 2.3% YoY rise in employee costs (₹157.73 Cr). On-book loans grew to ₹6,789.56 Cr from ₹6,000.83 Cr at FY26-end (+13.1% half-on-half).
The stock went into the print at ₹133.38, down 23.8% over the past month of trading.
For context: this is the second-highest quarterly PAT of the last 6 quarters; revenue is at a 6-quarter high.
What the summary numbers don't show
Basic EPS of ₹5.35 for the quarter (₹9.22 for H1 FY27) vs a loss per share a year ago; CRAR stood at a comfortable 36.75% and LCR at 148.97%.
AUM target ₹10,000 Cr by March 2027 (currently ₹7,702 Cr). NIM expected to expand 15-20 bps by year-end (range to 25 bps). Credit cost guidance ~2% annualized; OpEx to grow 4-5% initially, with 2-3% reduction targeted through branch rationalization.
— This quarter: met
Against the prior concall's guidance (AUM to ₹10,000 Cr by March 2027, credit cost ~2% annualized, NIM to expand 15-20 bps), the picture is broadly on-track but not fully verifiable from this filing alone: the on-book loan growth is directionally consistent with the AUM push (a web check confirms the ₹10,000 Cr FY27 target remains intact and Q1 FY27 AUM was ₹7,702 Cr), but this filing doesn't disclose a standalone AUM figure or NIM, so neither can be precisely checked here. Annualizing this quarter's impairment charge against the average loan book works out to roughly 2.3-2.4%, still a touch above the ~2% guided level even after nearly halving YoY. No quarter-specific Street consensus for Q2 FY27 PAT could be found (results were only announced today); the only available data point is a broader FY27 full-year consensus of 15-20% PAT growth, a bar this quarter's turnaround comfortably clears in direction if not in like-for-like percentage terms. Alongside the results, the board approved raising the MSME lending ticket-size ceiling from ₹25 lakh to ₹50 lakh, a product-diversification move tying into the growth push. The quarter also saw two senior exits — CSO Priyanka Seth Wadhera and CHRO Pooja Mehta (replaced by Chinmayi Trivedi) — which the numbers show no sign of disrupting operationally.
W1
AUM progress toward the ₹10,000 Cr FY27 target (₹7,702 Cr as of Q1 FY27); confirm the Q2 AUM figure at the concall/investor presentation since this filing discloses only on-book loans (₹6,789.56 Cr).
W2
Credit cost run-rate: this quarter's impairment annualizes to roughly 2.3-2.4% of the loan book, still above management's ~2% guided level even after nearly halving YoY.
W3
NIM trajectory against the guided 15-20 bps (up to 25 bps) expansion by FY27-end — not disclosed in this filing, pending concall confirmation.
Standalone only — company has no subsidiary/associate/JV (note 12), so no consolidated statement exists. Figures are unaudited (Limited Review Report). Tax expense is nil this quarter. No management press release was available separate from the regulatory filing.
Informational and educational content only. Not investment advice.